cilengitide has been researched along with nps2143 in 1 studies
| Studies (cilengitide) | Trials (cilengitide) | Recent Studies (post-2010) (cilengitide) | Studies (nps2143) | Trials (nps2143) | Recent Studies (post-2010) (nps2143) |
|---|---|---|---|---|---|
| 194 | 29 | 133 | 22 | 0 | 10 |
| Protein | Taxonomy | cilengitide (IC50) | nps2143 (IC50) |
|---|---|---|---|
| Beta-2 adrenergic receptor | Homo sapiens (human) | 0.0043 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.2 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.002 | |
| Extracellular calcium-sensing receptor | Homo sapiens (human) | 0.0285 | |
| Extracellular calcium-sensing receptor | Rattus norvegicus (Norway rat) | 0.495 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.2 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.0985 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, JG; Babij, P; Fotsch, C | 1 |
1 review(s) available for cilengitide and nps2143
| Article | Year |
|---|---|
Emerging targets in osteoporosis disease modification.
Topics: Animals; Biomarkers; Bone Density; Bone Resorption; Humans; Osteoporosis | 2010 |